Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

As it gets harder to offer compounded GLP-1s, many telehealth companies are pivoting to hormone replacement therapy.

Compounded versions of popular drugs used for weight loss including Wegovy and Zepbound will soon no longer be available ...

ABC News' Dr. Tara Narula breaks down the FDA's decision to stop the making of compound versions of weight loss medications.